Correction: MiR-30a-5p Antisense Oligonucleotide Suppresses Glioma Cell Growth by Targeting SEPT7

Correction: MiR-30a-5p Antisense Oligonucleotide Suppresses Glioma Cell Growth by Targeting SEPT7

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795152/?tool=EBI

Similar Items

Correction: MiR-30a-5p Antisense Oligonucleotide Suppresses Glioma Cell Growth by Targeting SEPT7.
by: Zhifan Jia, et al.
Published: (2013-01-01)

Retraction: MiR-30a-5p Antisense Oligonucleotide Suppresses Glioma Cell Growth by Targeting SEPT7.
by: PLOS ONE Editors
Published: (2020-01-01)

Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency
by: Patutina, OA, et al.
Published: (2020)

miR-302e Suppresses Glioma Progression by Targeting VEGFA
by: Xie Y, et al.
Published: (2020-10-01)

MiR-137 targets and regulates E2F7 to suppress progression of glioma cells
by: Jun Li, et al.
Published: (2022-09-01)

Selective targeting of MYC by antisense oligonucleotides
by: Gill, Taylor Elizabeth
Published: (2018)

Topographic Distribution of miRNAs (miR-30a, miR-223, miR-let-7a, miR-let-7f, miR-451, and miR-486) in the Plasma Extracellular Vesicles
by: Tatiana Petrova, et al.
Published: (2024-02-01)

Enhancement of SMN2 exon 7 inclusion by antisense oligonucleotides targeting the exon.
by: Yimin Hua, et al.
Published: (2007-04-01)

Targeting Smyd3 by next-generation antisense oligonucleotides suppresses liver tumor growth
by: Haroula Kontaki, et al.
Published: (2021-05-01)

RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
by: Sarah Bajan, et al.
Published: (2020-01-01)

Antisense miR-7 Impairs Insulin Expression in Developing Pancreas and in Cultured Pancreatic Buds
by: Margarita Nieto, et al.
Published: (2012-08-01)

Acceleration of Diabetic Wound Healing with PHD2- and miR-210-targeting Oligonucleotides
by: Dallas, Anne, et al.
Published: (2021)

Acceleration of Diabetic Wound Healing with PHD2- and miR-210-targeting Oligonucleotides
by: Dallas, Anne, et al.
Published: (2022)

Tumor-Suppressive and Immunomodulating Activity of miR-30a-3p and miR-30e-3p in HNSCC Cells and Tumoroids
by: Ombline Conrad, et al.
Published: (2023-07-01)

Making Sense of Antisense Oligonucleotide Therapeutics Targeting Bcl-2
by: Maria Gagliardi, et al.
Published: (2022-01-01)

Cyclodextrin-Based Nanoparticles for Delivery of Antisense Oligonucleotides Targeting Huntingtin
by: Monique C. P. Mendonça, et al.
Published: (2023-02-01)

Selective targeting of MYC mRNA by stabilized antisense oligonucleotides
by: Gill, Taylor, et al.
Published: (2024)

Improving Cardiac Delivery of Antisense Oligonucleotides with Peptidomimetic Targeting Agents
by: Antilla, Sarah An-ning
Published: (2023)

Use of antisense oligonucleotides to target Notch3 in skeletal cells.
by: Ernesto Canalis, et al.
Published: (2022-01-01)

Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer Therapeutics
by: Bao T. Le, et al.
Published: (2019-03-01)

Use of antisense oligonucleotides to target Notch3 in skeletal cells
by: Ernesto Canalis, et al.
Published: (2022-01-01)

miRNA and antisense oligonucleotide-based α-synuclein targeting as disease-modifying therapeutics in Parkinson’s disease
by: Vasanti Suvarna, et al.
Published: (2022-11-01)

Suppression of miR-221 inhibits glioma cells proliferation and invasion via targeting SEMA3B
by: Guilan Cai, et al.
Published: (2015-01-01)

GPX7 Is Targeted by miR-29b and GPX7 Knockdown Enhances Ferroptosis Induced by Erastin in Glioma
by: Yan Zhou, et al.
Published: (2022-01-01)

miR-137: A Novel Therapeutic Target for Human Glioma
by: Yajun Wang, et al.
Published: (2020-09-01)

Correction: A Tandem Oligonucleotide Approach for SNP-Selective RNA Degradation Using Modified Antisense Oligonucleotides.
by: Dorota Magner, et al.
Published: (2016-01-01)

MiR-22 Suppresses BMP7 in the Development of Cirrhosis
by: Dong Ji, et al.
Published: (2015-06-01)

Silencing Antibiotic Resistance with Antisense Oligonucleotides
by: Saumya Jani, et al.
Published: (2021-04-01)

In-silico study of antisense oligonucleotide antibiotics
by: Erica S. Chen, et al.
Published: (2023-11-01)

Antisense Oligonucleotides: Concepts and Pharmaceutical Applications
by: Ariana Araya, et al.
Published: (2023-02-01)

Towards understanding and applications of antisense oligonucleotides
by: Nguyen, Le Tuan Anh
Published: (2020)

History of Research on Antisense Oligonucleotide Analogs
by: Jack S. Cohen
Published: (2021-03-01)

Antisense Oligonucleotide-Based Therapy on miR-181a-5p Alleviates Cartilage Degradation of Temporomandibular Joint Osteoarthritis via Promoting SIRT1
by: Hexu Qi, et al.
Published: (2022-06-01)

Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection.
by: Yuanyuan Qiao, et al.
Published: (2023-01-01)

Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection
by: Yuanyuan Qiao, et al.
Published: (2023-01-01)

Targeting TGFβ Signaling to Address Fibrosis Using Antisense Oligonucleotides
by: James T. March, et al.
Published: (2018-06-01)

Publisher Correction: Dynamic and static control of the off-target interactions of antisense oligonucleotides using toehold chemistry
by: Chisato Terada, et al.
Published: (2024-01-01)

Long non-coding RNA TUSC7 plays tumor-suppressing roles in human gliomas by miR-23b
by: Chao Shang, et al.
Published: (2016-10-01)

MiR-221/222 target the DNA methyltransferase MGMT in glioma cells.
by: Cristina Quintavalle, et al.
Published: (2013-01-01)

Antisense Oligonucleotide Therapeutic Approach for Suppression of Ataxin-1 Expression: A Safety Assessment
by: Brennon O’Callaghan, et al.
Published: (2020-09-01)